Uy DS8201 Iphase

DS8201 Iphase

Qisqacha tavsif:

DS-8201a, also known as trastuzumab deruxtecan (T-DXd), is an antibody-drug conjugate (ADC) designed for the treatment of HER2-positive cancers. It combines a HER2-targeting monoclonal antibody (similar to trastuzumab) with a potent topoisomerase I inhibitor (deruxtecan) as the cytotoxic payload. The drug delivers chemotherapy directly to cancer cells expressing HER2, improving efficacy while limiting damage to normal cells.

Hozir bilan bog'laning Savatga qo'shish

Mahsulot tafsilotlari

Mahsulot teglari

Mahsulotni hisobga olish DS - 82011 Trastuzumab Deruxtema (t - DXD) deb nomlanuvchi, shuningdek, uni davolash uchun mo'ljallangan dorining kontiuugi (ADC) Bu uning elliklarini birlashtiradi. - Sitotokoksik yuklar sifatida i inhibitor (Deruxtecan) bilan Monoklonal antijaza (Trastuzumabga o'xshash). Preparat kimyoterapiyani to'g'ridan-to'g'ri saraton hujayralarini ekranli hujayralarga, normal hujayralarga zarar etkazayotganda, uni ekspluatatsiya qilishni yaxshilaydigan saraton kasalligini oshiradi.

Kategoriya:
Kattakon
No Noe:
015200.02
Birlik hajmi:
200sul, 2mg / ml
To'qima:
N / a
Turlari:
N / a
Saqlash sharoitlari va transport:
Do'kon 70 ° C. Quruq muz etkazib berildi.